BioHarvest Sciences to present at Canaccord Genuity growth conference in August
CEO Zaki Rakib will speak at the conference in Boston and hold investor meetings, the company said in a filing dated July 29, 2026.
BioHarvest Sciences Inc. (NASDAQ: BHST, FSE: 8MV0) announced on July 29, 2026 that its Chief Executive Officer, Zaki Rakib, will present at the upcoming Canaccord Genuity 46th Annual Growth Conference, to be held on August 11-13, 2026, in Boston, Massachusetts.1
Beyond the presentation, Dr. Rakib will also be participating in one-on-one investor meetings from August 11-12.1
The company's presentation is set for Wednesday, August 12, 2026, at 1:00 p.m. ET, presented by Zaki Rakib, Chief Executive Officer, in person at Abigail Adams C, InterContinental Hotel, Boston, MA, with an online webcast available.1 The filing noted that the live online webcast is publicly accessible for all online pre-registrants, and registration is mandatory for in-person conference participation.1
For those seeking direct engagement, investors attending the conference may request a one-on-one meeting with BioHarvest Sciences through their Canaccord Genuity representative.1
The company described the conference as bringing together institutional investors from across the globe with some of the best and most promising growth companies in the Technology, Healthcare & Life Sciences, Sustainability, Industrials, and Consumer & Retail sectors.1
In its company description, BioHarvest said it is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant.1 The company added that it operates within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products based on its botanical synthesis technology.1
The release included standard forward-looking statement cautions, noting that these statements are based on management's current expectations, beliefs, and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.